Inhibrx, Inc. Intellectual Property Contracts & Agreements
7 Contracts & Agreements
- License Agreements (7 contracts)
- Option and License Agreement, dated June 9, 2020, by and between the Registrant and bluebird bio, Inc (Filed With SEC on July 28, 2020)
- License Agreement, dated December 20, 2018, by and between the Registrant and bluebird bio, Inc (Filed With SEC on June 3, 2019)
- License Agreement, dated April 30, 2018, by and between the Registrant and Elpiscience Biopharmaceuticals, Inc (Filed With SEC on June 3, 2019)
- License Agreement, dated February 28, 2018, by and between the Registrant and Elpiscience Biopharmaceuticals, Inc (Filed With SEC on June 3, 2019)
- License Agreement, dated June 21, 2017, by and between the Registrant and Hangzhou Just Biotherapeutics Co., Ltd (Filed With SEC on June 3, 2019)
- Amendment to License Agreement, dated November 23, 2018, by and among the Registrant, INBRX 103, LLC and Celgene Corporation (Filed With SEC on June 3, 2019)
- License Agreement, dated July 1, 2013, by and between INBRX 103, LLC and Celgene Corporation (Filed With SEC on June 3, 2019)
